Making it in Manufacturing

Before CPHI Milan 2026, Tom and Elliot put seven questions to each other about what CPHI means, how to make the most of it, and what ARTO is bringing to the show as its official podcast partner.

Thomas McMann, host of Making It In Manufacturing, and Elliot Payne, co-founder of ARTO, answer them on a street corner, a rooftop, an arcade and the local pub, one question at a time.

In this episode, Tom and Elliot cover:

(00:11) Why they're excited for a second CPHI: three days of face-to-face meetings, when most business now happens over Teams.

(00:36) What the official podcast partnership means for ARTO: conversations with influential leaders from across the CDMO and pharmaceutical space, content from the show all week, and a panel with three CEOs.

(01:29) Advice for first-timers: embrace the chaos, bring your trainers, and make the most of everything happening around the show.

(02:28) What a good CPHI looks like for a CDMO: strengthening current partnerships, finding new ones, and building the pipeline for the year ahead.

(02:52) What makes CPHI special: everybody is there, the event runs like clockwork, and the booths are built to the nth degree.

(04:05) What success looks like for ARTO in Milan, and how the partnership with CPHI builds on it.

(04:54) The booths they can't wait to see this year.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent/

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent

TikTok: https://www.tiktok.com/@artotalent

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

Elliot Payne LinkedIn: https://www.linkedin.com/in/elliot-payne-2a4a917a/

Thomas McMann LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

00:00 Introduction

00:11 Are you excited for CPHI?

00:36 What the podcast partnership means for ARTO

01:29 Advice for first-timers

02:28 A good CPHI for a CDMO

02:52 What makes CPHI so special

04:05 What success looks like for ARTO

04:54 The booths to see

05:35 See you in Milan

#ARTOTalent #CPHI #CPHIMilan #CPHIMilan2026 #CDMO #PharmaIndustry #PharmaEvents #MakingItInManufacturing

Hosted on Acast. See acast.com/privacy for more information.

For three days every year, the global pharmaceutical industry comes together in one place. For Dr. Abdelaziz Toumi, that makes CPHI much more than a trade show: it is the industry's pulse check.

This week on Making It In Manufacturing, Thomas McMann sat down with Dr. Abdelaziz Toumi, CEO of Lupin Manufacturing Solutions, ahead of CPHI Milan 2026.

In this episode, Abdel covers:

(00:37) Why CPHI is much more than a trade show, and how three days give a pulse check on where investment, customer challenges and manufacturing trends are heading.

(02:05) The customer who walked onto the Lupin stand with no meeting booked, needing capacity after an acquisition, and the solution that followed a few months later.

(03:05) His panel on API security in a fragmented world, and why geopolitics, supply chain disruption and rising regulatory expectations have made supply security a strategic priority, with CDMOs at its centre.

(05:42) What Lupin Manufacturing Solutions hopes to achieve at the show, starting with listening to customers, and its investment in high potency APIs and specialised manufacturing.

(07:19) The themes he expects to dominate CPHI: specialisation, strategic partnerships, resilience and speed, and AI.

(10:20) His advice for first-time attendees: prepare well, stay curious, and choose quality conversations over a stack of business cards.

Recorded before the show, this conversation is a clear guide to what the industry came to Milan to talk about. Listen to the full episode to hear why Abdel believes pharma is, above all, a people business built on trust.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent/

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent

TikTok: https://www.tiktok.com/@artotalent

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

Dr. Abdelaziz Toumi LinkedIn: https://www.linkedin.com/in/abdelaziztoumi/

Thomas McMann LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

00:00 Introduction

00:37 What CPHI is, in Abdel's words

01:41 Years at CPHI and what keeps him coming back

02:05 The walk-in customer with no meeting booked

03:05 Abdel's panel: API security in a fragmented world

04:21 Why CDMOs are critical to supply chain resilience

05:42 What Lupin Manufacturing Solutions hopes to achieve

07:19 The key themes for this year's show

08:58 AI in pharmaceutical development and manufacturing

09:56 Making medicine affordable beyond the Western world

10:20 Advice for first-time attendees

11:55 Why pharma is a people business

12:24 Closing thoughts

#MakingItInManufacturing #ARTOTalent #CPHI #CPHIMilan #CDMO #PharmaManufacturing #PharmaSupplyChain #APISecurity #PharmaIndustry

Hosted on Acast. See acast.com/privacy for more information.

Across pharma, companies face the same sustainability challenges, yet most are still trying to solve them alone. A new summit at CPHI Milan is designed to change that. This week on Making It In Manufacturing, Thomas McMann sat down with Silvia Forroova, Director of Partnerships and Sustainability at CPHI, with almost 20 years of experience in the events industry spanning strategic partnerships, sustainability strategy and the global CPHI events portfolio within Informa Markets. In this episode, Silvia covers: (02:21) Why the CPHI Sustainability Collective was created, after years of conversations with manufacturers, packaging designers and suppliers revealed an industry tackling shared sustainability challenges in isolation. (04:24) What the Sustainability Summit is: a two-day collaborative platform for pharmaceutical professionals, built around discussion, action and knowledge exchange rather than passive listening. (06:51) How the summit's format differs from the main CPHI show. It is deliberately more intimate, with 20+ roundtables, interactive discussions and peer-to-peer working groups, plus keynotes from Sony Kapoor and Barbara Hook. (11:26) Why sustainability now warrants its own platform, with regulation, investors, patients and industry experts all pushing it from a compliance checkbox to a strategic priority. (16:59) The thinking behind CPHI's first hackathon, where mixed teams of buyers, suppliers and manufacturers develop and pitch practical solutions to real sustainability challenges. For anyone working through decarbonisation, packaging, supply chain or regulatory pressures, this conversation offers a clear view of how the industry is starting to tackle them together. Watch the full episode to hear what Silvia hopes the first summit will achieve.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

Silvia Forroova LinkedIn: https://www.linkedin.com/in/silvia-forroova-b871861b/

Thomas McMann LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Hosted on Acast. See acast.com/privacy for more information.

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes.

This week on Making It In Manufacturing, Thomas McMann sat down with Tara Dougal, Event Director for CPHI Milan.

In this episode, Tara covers:

• Why CPHI Milan 2026 is built around doing a year's worth of business in three days, and what that looks like for the 60,000 people expected through the doors.

• What's brand new for 2026, including the Sustainability Summit running across days one and two, and the day zero welcome reception in central Milan.

• Why the Startup Hub keeps growing, as pharma increasingly buys its innovation in from universities and early-stage companies rather than developing it internally.

• How new zones for AI & Tech, cold chain logistics, contamination control and labelling came directly out of industry feedback.

• Practical advice for first-time attendees on planning ahead, navigating Fiera Milano, and getting the most out of three very busy days.

Be sure to watch this episode if you're attending CPHI Milan to get a complete overview of the agenda and key highlights.

Even if you won't be there in person, it's still worth tuning in to stay up to date with the latest CPHI news, announcements, and live event updates.

Follow ARTO LinkedIn: https://www.linkedin.com/company/artotalent/

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent

TikTok: https://www.tiktok.com/@artotalent

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/channel/UCkoSWF_xqX4i9OIkX4pGaxQ

Tara Dougal LinkedIn: https://www.linkedin.com/in/taradougal/

Thomas McMann LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b

Timestamps:

00:00 Introduction

00:54 Tara's role as Event Director

02:00 What CPHI is and who attends

03:21 How Milan compares to Frankfurt

03:57 What's brand new for 2026

04:03 The Sustainability Summit

04:59 New networking events and the day zero reception

05:33 The content programme and standout sessions

06:56 Why the Startup Hub is growing

08:34 Inside the CPHI Awards evening

10:50 The new zones and where the ideas came from

12:52 How CPHI plans the following year

14:05 A first look at 2027

14:38 Advice for first-time attendees

16:08 Getting to and around Fiera Milano

17:49 Running a show for 60,000 people

18:28 Tara's role during the live event

19:47 What Tara is most excited about

20:44 Why you should come to CPHI Milan 2026

#MakingItInManufacturing #ARTOTalent #CPHIMilan #PharmaceuticalManufacturing #CDMO #PharmaServices #SupplyChain #PharmaIndustry #DrugDevelopment #PharmaEvents

Hosted on Acast. See acast.com/privacy for more information.

What does it take to manage multi-billion dollar pharmaceutical projects while balancing technical complexity, stakeholder alignment, and constant change?

In this episode, Hans Lindenberg Stentoft shares lessons from leading major capital projects at @Novo Nordisk, why CIP is often overlooked, and how preparation, communication, and early decision making can determine project success.

This week on Making It In Manufacturing, Thomas McMann sat down with Hans Lindenberg Stentoft, Project Manager, with over 6 years of experience spanning project management across utility, CIP and facility work packages, following earlier experience as a student assistant, data analyst and engineering placements in manufacturing and supply chain.

Hosted on Acast. See acast.com/privacy for more information.

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes.

This week on Making It In Manufacturing, Thomas McMann sat down with Chris Leman (UK Chair), Trina Ives (NE Chair), and Zam Thahir (EAC Chair), the UK leadership of ISPE UK , recorded at AstraZeneca's site in Macclesfield during the first ISPE UK Emerging Leaders Conference.

In this episode, the team covers:

- What ISPE is and why life sciences professionals beyond engineering should get involved

- How each leader first got involved with ISPE and progressed through the regional committees

- The 2024 annual event in Manchester, the new industry awards and the awards dinner

- What to expect at your first ISPE event and why the community feels so welcoming

- The 2026 annual event in Newcastle, the Leadership Summit at GSK and plans to expand across the UK

If you work anywhere in life sciences and have wondered how to build a network that opens doors across the industry, this conversation is a clear and honest look at what membership can offer. Watch the full episode to hear how Chris, Trina and Zam are investing in the people who will shape UK pharma next.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

Chris Leman

LinkedIn: https://www.linkedin.com/in/chrisleman/

Trina Ives

LinkedIn: https://www.linkedin.com/in/trinaives/

Zam Shabeer Thahir

LinkedIn: https://www.linkedin.com/in/zam-shabeer-thahir-0a18a74b/

Thomas McMann (Host)

LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

00:14 Introductions from Chris, Trina and Zam

01:08 The March board handover and the first few months as chair

02:01 Turnout at the Emerging Leaders Conference and shout out to Chalisa

03:21 The first Emerging Leaders Conference and getting 62 students involved

04:00 What ISPE is and the scale of the global membership

05:32 You don't have to be an engineer to join ISPE

06:07 How Chris first got involved through the North West committee

08:38 Trina's journey from marketing executive to Vice Chair

10:34 Zam's journey from a 2016 site tour to chair

12:21 Growing emerging leaders events and the Growth Fund initiative

14:29 Favourite memories and the 2024 annual event in Manchester

16:53 Trina on the member of the year award and the North East community

17:37 What to expect at your first ISPE event

19:03 Zam on site tours and the social side of ISPE

21:42 A good first step for anyone wanting to get involved

22:49 The 2026 Newcastle annual event and the Leadership Summit at GSK

25:31 Expanding ISPE across Wales, Scotland and Northern Ireland

27:13 The Bridge to Innovation theme, EduHub and the pre-conference social

28:44 Where to find out more and the value of the ISPE UK LinkedIn page

29:51 Closing thoughts

#MakingItInManufacturing #ARTOTalent #ISPE #Pharma #PharmaceuticalEngineering #LifeSciences #Manufacturing #EmergingLeaders #PharmaCareers #Networking

Hosted on Acast. See acast.com/privacy for more information.

This week on Making It In Manufacturing, Thomas McMann sat down with Thomas Emerik Rasmussen, a project and operations leader specialising in lean manufacturing and operational excellence, with over 15 years at Novo Nordisk spanning nine different roles across Denmark, Italy and the United States, building and leading large CapEx expansion projects before moving into consulting to help companies transform their quality operations.

In this episode, Thomas covers:

• How an unconventional start as a management consultant shaped a career built on teams, mission and visible purpose
• Why the API expansion in Clayton, North Carolina, the biggest pharma investment in the world when it broke ground in 2015, became a career-defining project
• What made the 2.9 billion QC facility unique, and why stakeholder management across five different cultures proved harder than the construction itself
• How the design one, build many model cuts years off design, construction and regulatory timelines, with Fujifilm Biotechnologies cited as another adopter
• Where AI, digital twins and modular design are taking facility design next, drawing on examples shared by Roche at the ISPE conference

If you work in pharmaceutical manufacturing, operational excellence or facility design, this conversation offers a grounded look at how one of the industry's most successful scale-up stories was actually built, and where it goes from here. Worth your time from start to finish.

Follow ARTO

LinkedIn:   / artotalent  

Spotify: https://open.spotify.com/show/0kEcRZO...

Instagram: https://www.instagram.com/arto.talent...

TikTok: https://www.tiktok.com/@artotalent?_t...

Apple Podcasts: https://podcasts.apple.com/us/podcast...

Website: https://arto-talent.com/

Youtube:    / @artotalent  

LinkedIn:

Thomas Emerik Rasmussen

  / thomas-emerik-rasmussen-82b2981  

Thomas McMann

  / thomas-mcmann-05540a10b  

Timestamps:

00:00 Introduction

01:21 Welcome to the podcast

01:34 Getting into engineering and lean manufacturing

03:31 Family, mentors and the draw to life sciences

04:50 Starting out as a management consultant

06:05 Advising medtech companies as a fresh graduate

07:08 Joining Novo Nordisk and an early promotion

09:10 Staying engaged across nine different roles

11:13 The proudest project: API expansion in Clayton, North Carolina

12:27 Relocating the family to the United States

13:17 The secret behind Novo Nordisk's growth

15:42 Scaling the business and optimising existing lines

16:04 Underestimating volumes and quadrupling API capacity

17:20 Separating operations from the CapEx organisation

19:51 The 2.9 billion QC facility and why it was unique

22:37 Innovation, automation and material handling

24:32 Project status and timeline to completion

25:21 The design one, build many model explained

27:10 The major benefits of modular design

29:13 Why more companies are adopting modular thinking

31:02 Keeping innovation alive within a standardised approach

32:37 How lean and operational excellence enable rapid expansion

34:03 Methodologies: value stream mapping

35:11 A wind turbine case study and a 25% lead time reduction

37:17 The lean mindset built into the API expansion

39:47 The biggest opportunities for innovation in facility design

41:18 Digital twins, AI and the future of facility flow

43:57 The risks around AI in design and regulation

44:57 Takeaways from the ISPE conference in the UK

45:27 Key lessons from scaling operations

48:36 The one thing he would have done differently

51:14 Closing thoughts

#MakingItInManufacturing #ARTOTalent #Pharma #PharmaceuticalManufacturing #LifeSciences #OperationalExcellence #LeanManufacturing #QualityControl #FacilityDesign #NovoNordisk #CapEx #ModularDesign

Hosted on Acast. See acast.com/privacy for more information.

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes.

What does it actually take to deliver a pharmaceutical facility project without it going off the rails? This week, Thomas McMann sat down with someone who has spent over 30 years doing exactly that, from both sides of the table.

This week on Making It In Manufacturing, Thomas McMann sat down with Bruce Klopfenstein, Project Manager at GSK, with over 30 years of experience spanning project management, engineering, validation, EPC consulting, and client-side leadership across companies including GSK, Jacobs, JohnsonAndJohnson, Fujifilm and IBM.

In this episode, Bruce covers:

- Why getting ACV engaged at the very start of a project changes everything, and why the industry has been slow to do it.

- Who is actually responsible when a pharmaceutical project goes over budget, and why change control is almost always at the root of it.

- The $100,000 mistake that came down to a missing piece of paper, and the engineer who had to fly to Europe during Covid to fix it.

- How GSK is leading a major sustainability push through its low-carbon inhaler propellant project in France, and why 49% of their total annual emissions trace back to a single product type.

- Why AI adoption in pharmaceutical validation is no longer optional, and how companies like GSK and Eli Lilly are already using it inside the firewall, with Bruce's take on ValKit AI and what large language models can do for protocol generation at scale.

This is a genuinely experienced perspective on what it takes to manage complex pharmaceutical projects, and what the industry needs to do differently. Worth your time whether you are on the EPC side, the client side, or deep in the validation world.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

LinkedIn

Bruce Klopfenstein

LinkedIn: https://www.linkedin.com/in/bruceklopfenstein/

Thomas McMann

LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

0:00 Introduction

1:40 Bruce's ISP talk: early ACV engagement from Basis of Design through Detailed Design

3:13 Bruce's career journey: IBM, PricewaterhouseCoopers, gaming industry, J&J, and life science

8:09 Finding the most enjoyable moments: it is about the team and the situation, not just the job

13:13 Engineering complexity of the 152A propellant transition and where the project currently stands

16:33 The CO2 comparison between pharma and automotive: why the headline is misleading

19:54 Who is responsible when a project goes over budget? EPC vs client-side accountability

23:08 The biggest differences between working on the EPC side vs the client side

25:20 Why relationships are the foundation of every successful project

30:10 EPC stress vs owner stress: where the real pressure sits

36:18 Why pharma struggles to standardise the way oil and gas has

40:04 Change control in practice: what it actually requires

43:07 Equipment lead times and Covid-era supply chain pressure on the critical path

45:44 AI in pharmaceutical validation: where the industry is today

46:26 ValKit AI and Hugh Devine: using LLMs to generate validation protocols

47:18 The FDA's first AI warning letter and what it means for human oversight

53:31 How to think about AI like a smart intern: natural language, not programming

55:38 Why companies that are not adopting AI now will fall behind

56:00 Closing thoughts and sign-off

#MakingItInManufacturing #ARTOTalent #ProjectManagement #Validation #LifeSciences #Biotech #AIInPharma #Commissioning #GMP #DrugManufacturing #Sustainability #GSK #EPC

Hosted on Acast. See acast.com/privacy for more information.

What does it take to transform a biologics manufacturing business into a global CDMO leader while keeping culture, transparency and patient impact at the centre of every decision?

This week on Making It In Manufacturing, Thomas McMann sat down with Lars Petersen, CEO of Fujifilm Biotechnologies, with more than 30 years of experience spanning biologics manufacturing, engineering, operations leadership, global site leadership and biotech innovation across Novo Nordisk, Genentech, Roche and Biogen.

In this episode, Lars covers:

• Why “Partners for Life” became the foundation of Fujifilm Biotechnologies’ long-term customer strategy and how transparency reshaped CDMO partnerships

• How personal loss, engineering curiosity and early leadership experiences at Novo Nordisk shaped Lars’ approach to people, manufacturing and patient impact

• Lessons from the California biotech ecosystem at Genentech and Roche, including how culture and scientific purpose influenced leadership philosophy

• How the KojoX modular manufacturing platform is helping reduce engineering timelines, improve scalability and rethink biologics facility design

• Why AI will transform pharmaceutical manufacturing and how Fujifilm Biotechnologies is preparing the next evolution of biologics production

Lars shares an honest perspective on leadership, scaling culture globally, operational excellence and the future of biologics manufacturing. For anyone working across biotech, pharma manufacturing, CDMOs or advanced therapies, this conversation offers a rare look into the mindset behind one of the industry’s fastest-growing organisations.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

Lars Petersen

LinkedIn: https://www.linkedin.com/in/lars-petersen-5134362/

Thomas McMann

LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

02:14 Introduction to Lars Petersen and Fujifilm Biotechnologies

03:09 The meaning behind “Partners for Life”

06:35 Growth of Fujifilm and the secrets behind its success

07:26 How CDMOs are becoming strategic partners for pharma

08:41 Lars' journey into pharmaceuticals and personal motivation

10:47 Did Lars always want to become a CEO?

12:12 Engineering mindset vs. people leadership

13:55 Advantages of a technical background as a CEO

16:27 Lessons from 16 years at Novo Nordisk

19:15 Leaving comfort zones: moving to China and the United States

21:33 California, Genentech, and biotech culture

24:39 Lessons from Genentech and Roche

27:13 Leading the Biogen site acquisition by Fujifilm

32:03 Winning the first customer and validating the vision

34:11 The vision to become the “TSMC of biotech”

36:19 KojoX: Fujifilm's modular manufacturing platform

41:43 Defining a People-First culture

45:57 Maintaining culture while scaling globally

48:37 Self-awareness and leadership development

53:39 AI in biomanufacturing and the future of KojoX

55:10 What still motivates Lars after 30+ years in biotech

56:18 David Bowie, legacy, and final reflections

56:39 Closing remarks

#MakingItInManufacturing #ARTOTalent #Biotech #PharmaceuticalManufacturing #CDMO #Biologics #AdvancedTherapies #CellTherapy #GeneTherapy #LifeSciences #ManufacturingLeadership

Hosted on Acast. See acast.com/privacy for more information.

95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes.

This week on Making It In Manufacturing, Thomas McMann sat down with Sarah Griffin, Event Manager for CPHI Americas. In this episode, Sarah covers:

• Why CPHI Americas is creating a more focused, content-led experience built around meaningful industry conversations and strategic partnerships.

• How the event has evolved to meet growing demand for deeper engagement between pharmaceutical companies, CDMOs, technology providers, regulators, and investors.

• Why CDMOs are moving from outsourced service providers to long-term strategic partners, with greater transparency, collaboration, and shared risk.

• How pharmaceutical companies are balancing supply chain resilience, regionalisation, outsourcing strategies, and operational agility in a changing global market.

• What will define the next phase of growth for pharmaceutical services, including advanced therapies, AI integration, talent development, and partnership-driven business models.

Be sure to watch this episode if you're attending CPHI Americas to get a complete overview of the agenda and key highlights. Even if you won't be there in person, it's still worth tuning in to stay up to date with the latest CPHI news, announcements, and live event updates.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@artotalent

Sarah Griffin

LinkedIn: https://www.linkedin.com/in/sarah-griffin-cem/

Thomas McMann

LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

00:00 Introduction

00:48 What makes CPHI Americas different

02:20 Why the event is becoming more content-led

03:25 New features and event changes for this year

04:31 The purpose behind the Hot Seat sessions

05:28 Sarah’s outlook ahead of the event

05:54 How CDMO partnerships are evolving

07:53 Supply chain resilience and outsourcing strategies

09:08 Demand for integrated pharmaceutical services

10:18 What separates successful CDMOs from competitors

12:03 Future growth drivers in pharmaceutical services

13:16 Collaboration and raising industry standards

14:11 What Sarah is most excited about at CPHI Americas

15:23 Sessions Sarah is looking forward to attending

16:23 Quick fire round

16:42 Biggest trend dominating pharma conversations

16:58 Biggest concern for pharma leaders

17:12 What makes CPHI Americas different from other events

17:37 Industry conversations that need more openness

18:09 Closing thoughts

#MakingItInManufacturing #ARTOTalent #PharmaceuticalManufacturing #CDMO #PharmaServices #Biologics #CellAndGeneTherapy #SupplyChain #PharmaIndustry #DrugDevelopment

Hosted on Acast. See acast.com/privacy for more information.